clinical-trial is the sole category represented across all 1 tracked stories. Lab-grown Oesophagus is most often covered alongside Esophageal Atresia, which appears in 1 of these 1 story. Their average consequence score of 8 runs above the beat's 6.4 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Lab-grown Oesophagus
clinical-trial is the sole category represented across all 1 tracked stories. Lab-grown Oesophagus is most often covered alongside Esophageal Atresia, which appears in 1 of these 1 story. Their average consequence score of 8 runs above the beat's 6.4 for that window. Source depth averages 3 original sources per story, versus 2.8 across the same-window beat baseline. We currently track 1 Biotech story that mention Lab-grown Oesophagus, all published on March 20, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Lab-grown Oesophagus. Shared-story counts are live from our verified record — not editorial picks.
A groundbreaking medical milestone has been achieved with the development of the first lab-grown oesophagus, offering a transformative treatment for children born with rare congenital conditions. This regenerative medicine breakthrough uses tissue engineering to create functional organs, potentially replacing invasive surgeries that currently rely on repositioning other digestive organs.
Lab-grown Oesophagus is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.